Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04559035 · ClinicalTrials.gov registry record · NA
Nasal Irrigation to Reduce COVID-19 Morbidity
A NA study, sponsored by Augusta University.
- Completed
- Registry status
- NA
- Development phase
- 239
- Enrollment target
NCT04559035 is a NA study that has completed, run by Augusta University. The registered enrollment target is 239 participants.
The verdict
NCT04559035, a NA study, has completed, sponsored by Augusta University.
- COMPLETED
- Registry status
- NA
- Development phase
- 239 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate if using nasal irrigation, also known as nasal lavage, for 14 days after a positive test in high risk patients can reduce the severity of symptoms associated with COVID-19. Nasal lavage consists of running salt water in one nostril and out the other to get rid of germs. Nasal irrigation was done with either Betadine or baking soda to determine if adding an antimicrobial or changing the pH of the mucous helped. Hospitalization and death were compared for combined nasal irrigation groups to the CDC dataset of patients aged 50+
Interventions
- OTHER Nasal lavage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 239 participants |
| Start Date | 2020-09-24 |
| Est. Completion | 2021-11-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04559035
The ClinicalTrials.gov registry entry for NCT04559035 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 239 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Augusta University, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nasal lavage is the first listed.
NCT04559035 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04559035 about?
NCT04559035 is a clinical study titled "Nasal Irrigation to Reduce COVID-19 Morbidity". The purpose of this study is to evaluate if using nasal irrigation, also known as nasal lavage, for 14 days after a positive test in high risk patients can reduce the severity of symptoms associated with COVID-19. Nasal lavage consists of running salt water in one nostril and out the other to get ri...
What is the current status of trial NCT04559035?
This trial is currently completed. It is a NA study. The enrollment target is 239 participants. The study started on 2020-09-24. Estimated completion is 2021-11-04.
What interventions are being tested in trial NCT04559035?
The interventions under investigation include: Nasal lavage (OTHER).
Who is sponsoring clinical trial NCT04559035?
This trial is sponsored by Augusta University, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.